For Immediate Release Media Contact: Celia Sepulveda, Celia.Sepulveda@Micronoma.com, 858.337.1326 Micronoma Launches with $3 Million Seed Funding First early cancer-detection company to use microbial biomarkers in diagnostics San Diego, Calif....
From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...
UCSD team, and Micronoma founders, publish Nature paper identifying nucleic acid-based, tumor-specific microbial signatures in the blood, suggesting a new diagnostic approach.
Microbiome analyses of blood and tissues suggest cancer diagnostic approach.
Systematic characterization of the cancer microbiome provides the opportunity to develop techniques that exploit non-human, microorganism-derived molecules in the diagnosis of a major human disease.
Micronoma will be presenting at Biocom this year. Go to Biocom Micronoma San Diego, CA, USA email@example.com